NL6604606A - - Google Patents

Info

Publication number
NL6604606A
NL6604606A NL6604606A NL6604606A NL6604606A NL 6604606 A NL6604606 A NL 6604606A NL 6604606 A NL6604606 A NL 6604606A NL 6604606 A NL6604606 A NL 6604606A NL 6604606 A NL6604606 A NL 6604606A
Authority
NL
Netherlands
Application number
NL6604606A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00446395A external-priority patent/US3846456A/en
Application filed filed Critical
Publication of NL6604606A publication Critical patent/NL6604606A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
NL6604606A 1965-04-07 1966-04-06 NL6604606A (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US446396A US3380886A (en) 1965-04-07 1965-04-07 7alpha-methyl-3beta-hydroxy-5-androstenes
US00446395A US3846456A (en) 1965-04-07 1965-04-07 Organic compounds

Publications (1)

Publication Number Publication Date
NL6604606A true NL6604606A (xx) 1966-10-10

Family

ID=27034609

Family Applications (2)

Application Number Title Priority Date Filing Date
NL6604606A NL6604606A (xx) 1965-04-07 1966-04-06
NL6604607A NL6604607A (xx) 1965-04-07 1966-04-06

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL6604607A NL6604607A (xx) 1965-04-07 1966-04-06

Country Status (8)

Country Link
US (1) US3380886A (xx)
BE (2) BE679218A (xx)
CH (2) CH507224A (xx)
DE (1) DE1593621A1 (xx)
FR (2) FR5612M (xx)
GB (3) GB1146991A (xx)
IL (2) IL25391A (xx)
NL (2) NL6604606A (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7501563A (nl) * 1974-02-28 1975-09-01 Merck & Co Inc Werkwijze voor het bereiden van preparaten te- gen het samenpakken van bloedplaatjes.
US4297350A (en) * 1978-10-10 1981-10-27 The Upjohn Company Male contraceptive steroids and methods of use
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US5227375A (en) * 1990-02-08 1993-07-13 Endorecherche, Inc. Aromatase inhibitors
IT1277700B1 (it) * 1995-12-22 1997-11-11 Poli Ind Chimica Spa Processo di preparazione di 2-beta, 16-beta-diamino 3-alfa, 17-beta- diacilossi 5-alfaandrostani, bloccanti neuromuscolari a struttura
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
WO2002028880A2 (en) * 2000-10-06 2002-04-11 Aeson Therapeutics Inc. Compounds useful for treating hypertriglyceridemia
US20220169672A1 (en) * 2019-02-28 2022-06-02 Purdue Research Foundation Compounds for targeted therapies of castration resistant prostate cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3262949A (en) * 1956-11-13 1966-07-26 Syntex Corp 7-methyl androstane compounds
US3145221A (en) * 1957-11-27 1964-08-18 Syntex Corp 17alpha-lower alkyl, 17alpha-lower alkinyl and 17alpha-lower alkenyl derivatives of 19-nor-delta5-androsten-17beta-ol-3-one
US3029263A (en) * 1959-12-24 1962-04-10 Upjohn Co 7-methyl-4, 6-androstadienes
US3246021A (en) * 1960-04-20 1966-04-12 Merck & Co Inc Intermediates in the preparation of 6beta-methyl-halo ethisterone compounds
DE1249264B (de) * 1962-08-24 1967-09-07 The British Drug Houses Limited London Verfahren zur Her Stellung von neuen YIi Chlorathmyl 17ß alkoxysteroiden

Also Published As

Publication number Publication date
GB1146992A (en) 1969-03-26
BE679218A (xx) 1966-10-07
CH490359A (de) 1970-05-15
US3380886A (en) 1968-04-30
CH507224A (de) 1971-05-15
GB1146053A (en) 1969-03-19
IL25403A (en) 1970-07-19
FR5612M (xx) 1967-12-11
GB1146991A (en) 1969-03-26
DE1593613B2 (de) 1976-01-15
FR5794M (xx) 1968-02-12
BE679215A (xx) 1966-10-07
NL6604607A (xx) 1966-10-10
DE1593613A1 (de) 1970-08-13
IL25391A (en) 1970-01-29
DE1593621A1 (de) 1970-05-27

Similar Documents

Publication Publication Date Title
BE675684A (xx)
BE675550A (xx)
BE660388A (xx)
BE662704A (xx)
BE664265A (xx)
BE664693A (xx)
BE667500A (xx)
BE668544A (xx)
BE668937A (xx)
BE669135A (xx)
BE669525A (xx)
BE669636A (xx)
BE670000A (xx)
BE670151A (xx)
BE671032A (xx)
BE671675A (xx)
BE671749A (xx)
BE672301A (xx)
BE672509A (xx)
BE672641A (xx)
BE672822A (xx)
BE673130A (xx)
BE673232A (xx)
BE673298A (xx)
BE673358A (xx)